| http://www.w3.org/ns/prov#value | - Please discuss those circumstances, if any, under which FDA should take specific regulatory action regarding these investigational vaccines, such as stopping a clinical trial (pending an acceptable remedy of the product) or modification of the informed consent form.
|
